Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation
Journal of Thoracic Oncology - United States
doi 10.1097/jto.0000000000000170
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2014
Authors
Publisher
Elsevier BV